These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38902241)

  • 21. ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection.
    Thi EP; Dhillon AP; Ardzinski A; Bidirici-Ertekin L; Cobarrubias KD; Cuconati A; Kondratowicz AS; Kwak K; Li AHL; Miller A; Pasetka C; Pei L; Phelps JR; Snead NM; Wang X; Ye X; Sofia MJ; Lee ACH
    ACS Infect Dis; 2019 May; 5(5):725-737. PubMed ID: 30403127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.
    Wooddell CI; Yuen MF; Chan HL; Gish RG; Locarnini SA; Chavez D; Ferrari C; Given BD; Hamilton J; Kanner SB; Lai CL; Lau JYN; Schluep T; Xu Z; Lanford RE; Lewis DL
    Sci Transl Med; 2017 Sep; 9(409):. PubMed ID: 28954926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs.
    Xuan B; Qian Z; Hong J; Huang W
    Virus Res; 2006 Jun; 118(1-2):150-5. PubMed ID: 16423421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of replication of hepatitis B virus in transgenic mice following administration of hepatotropic lipoplexes containing guanidinopropyl-modified siRNAs.
    Marimani MD; Ely A; Buff MC; Bernhardt S; Engels JW; Scherman D; Escriou V; Arbuthnot P
    J Control Release; 2015 Jul; 209():198-206. PubMed ID: 25937322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA Interference inhibits hepatitis B virus of different genotypes in vitro and in vivo.
    Zhang YL; Cheng T; Cai YJ; Yuan Q; Liu C; Zhang T; Xia DZ; Li RY; Yang LW; Wang YB; Yeo AE; Shih JW; Zhang J; Xia NS
    BMC Microbiol; 2010 Aug; 10():214. PubMed ID: 20696079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploiting the RNA interference pathway to counter hepatitis B virus replication.
    Arbuthnot P; Carmona S; Ely A
    Liver Int; 2005 Feb; 25(1):9-15. PubMed ID: 15698393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
    Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in developing nucleic acid-based HBV therapy.
    Marimani M; Hean J; Bloom K; Ely A; Arbuthnot P
    Future Microbiol; 2013 Nov; 8(11):1489-504. PubMed ID: 24199806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
    Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
    Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
    Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080
    [No Abstract]   [Full Text] [Related]  

  • 31. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.
    Carmona S; Jorgensen MR; Kolli S; Crowther C; Salazar FH; Marion PL; Fujino M; Natori Y; Thanou M; Arbuthnot P; Miller AD
    Mol Pharm; 2009; 6(3):706-17. PubMed ID: 19159285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication.
    Gao L; Yang J; Feng J; Liu Z; Dong Y; Luo J; Yu L; Wang J; Fan H; Ma W; Liu T
    Front Immunol; 2022; 13():856463. PubMed ID: 35572586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas.
    Yang YC; Yang HC
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic inhibition of hepatitis B virus surface antigen expression by RNA interference.
    Cheng TL; Chang WW; Su IJ; Lai MD; Huang W; Lei HY; Chang WT
    Biochem Biophys Res Commun; 2005 Oct; 336(3):820-30. PubMed ID: 16153600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [RNA interference inhibits replication and expression of hepatitis B virus in mice].
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):630-4. PubMed ID: 15949363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunities for treating chronic hepatitis B and C virus infection using RNA interference.
    Arbuthnot P; Longshaw V; Naidoo T; Weinberg MS
    J Viral Hepat; 2007 Jul; 14(7):447-59. PubMed ID: 17576386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo.
    Gorsuch CL; Nemec P; Yu M; Xu S; Han D; Smith J; Lape J; van Buuren N; Ramirez R; Muench RC; Holdorf MM; Feierbach B; Falls G; Holt J; Shoop W; Sevigny E; Karriker F; Brown RV; Joshi A; Goodwin T; Tam YK; Lin PJC; Semple SC; Leatherbury N; Delaney Iv WE; Jantz D; Rhoden Smith A
    Mol Ther; 2022 Sep; 30(9):2909-2922. PubMed ID: 35581938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation.
    Tilsed CM; Sadiq BA; Papp TE; Areesawangkit P; Kimura K; Noguera-Ortega E; Scholler J; Cerda N; Aghajanian H; Bot A; Mui B; Tam Y; Weissman D; June CH; Albelda SM; Parhiz H
    Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2319856121. PubMed ID: 38513098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.